Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
349
Appointments
169
Departures
38
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,771 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | L3HARRIS TECHNOLOGIES, INC. /DE/ | Christopher Kubasik | member of the Company’s Boardmember of the Company’s Board | Departed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Paula A. Johnson, M.D., M.P.H. | Class III directorClass III director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Sophie Kornowski, Pharm.D. | Class I directorClass I director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Nancy C. Andrews, M.D., Ph.D. | Class III directorClass III director | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Nancy C. Andrews, M.D., Ph.D. | Class II directorClass II director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Hervé Hoppenot | Class II directorClass II director | Departed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Maze Therapeutics, Inc. | Hervé Hoppenot | Class III directorClass III director | Appointed | Aug 13, 2026 | SEC 8-K |
| Aug 17, 2026 | Neuronetics, Inc. | Francis X. Brown III | interim principal financial and accounting officerCFO | Departed | Aug 11, 2026 | SEC 8-K |
| Aug 17, 2026 | Neuronetics, Inc. | Nir Naor | principal financial and accounting officerCFO | Appointed | Aug 12, 2026 | SEC 8-K |
| Aug 17, 2026 | Neuronetics, Inc. | Nir Naor | Corporate SecretaryCorporate Secretary | Appointed | n/a | SEC 8-K |
| Aug 17, 2026 | NNN REIT, INC. | Christina Chiu | DirectorDirector | Appointed | Oct 1, 2026 | SEC 8-K |
| Aug 17, 2026 | NNN REIT, INC. | Charles “Chaz” D. Mueller, Jr. | DirectorDirector | Appointed | Oct 1, 2026 | SEC 8-K |
| Aug 17, 2026 | NNN REIT, INC. | Betsy D. Holden | DirectorDirector | Departed | Feb 19, 2027 | SEC 8-K |
| Aug 17, 2026 | PARK AEROSPACE CORP | Constantine Petropoulos | Senior Vice President and Chief Financial OfficerCFO | Appointed | Aug 12, 2026 | SEC 8-K |
| Aug 17, 2026 | Profound Medical Corp. | Matthew Sobczyk | Interim Chief Financial OfficerCFO | Appointed | Aug 14, 2026 | SEC 8-K |
| Aug 17, 2026 | Profound Medical Corp. | Rashed Dewan | Chief Financial OfficerCFO | Departed | Aug 14, 2026 | SEC 8-K |
| Aug 17, 2026 | RESMED INC | Ronald Taylor | directordirector | Departed | Nov 18, 2026 | SEC 8-K |
| Aug 17, 2026 | RESMED INC | Carol Burt | lead directorlead director | Appointed | Nov 15, 2026 | SEC 8-K |
| Aug 17, 2026 | Rocket Companies, Inc. | Sarah Watterson | Class III directorClass III director | Appointed | Aug 17, 2026 | SEC 8-K |
| Aug 17, 2026 | SCANSOURCE, INC. | Peter C. Browning | DirectorDirector | Departed | Aug 12, 2026 | SEC 8-K |
- L3HARRIS TECHNOLOGIES, INC. /DE/Departed
Christopher Kubasik member of the Company’s Board
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Paula A. Johnson, M.D., M.P.H. Class III director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Sophie Kornowski, Pharm.D. Class I director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Departed
Nancy C. Andrews, M.D., Ph.D. Class III director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Nancy C. Andrews, M.D., Ph.D. Class II director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Departed
Hervé Hoppenot Class II director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Maze Therapeutics, Inc.Appointed
Hervé Hoppenot Class III director
Filed Aug 17, 2026Effective Aug 13, 2026SEC 8-K
- Neuronetics, Inc.Departed
Francis X. Brown III CFO
Filed Aug 17, 2026Effective Aug 11, 2026SEC 8-K
- Neuronetics, Inc.Appointed
Nir Naor CFO
Filed Aug 17, 2026Effective Aug 12, 2026SEC 8-K
- Neuronetics, Inc.Appointed
Nir Naor Corporate Secretary
Filed Aug 17, 2026SEC 8-K
- NNN REIT, INC.Appointed
Christina Chiu Director
Filed Aug 17, 2026Effective Oct 1, 2026SEC 8-K
- NNN REIT, INC.Appointed
Charles “Chaz” D. Mueller, Jr. Director
Filed Aug 17, 2026Effective Oct 1, 2026SEC 8-K
- NNN REIT, INC.Departed
Betsy D. Holden Director
Filed Aug 17, 2026Effective Feb 19, 2027SEC 8-K
- PARK AEROSPACE CORPAppointed
Constantine Petropoulos CFO
Filed Aug 17, 2026Effective Aug 12, 2026SEC 8-K
- Profound Medical Corp.Appointed
Matthew Sobczyk CFO
Filed Aug 17, 2026Effective Aug 14, 2026SEC 8-K
- Profound Medical Corp.Departed
Rashed Dewan CFO
Filed Aug 17, 2026Effective Aug 14, 2026SEC 8-K
- RESMED INCDeparted
Ronald Taylor director
Filed Aug 17, 2026Effective Nov 18, 2026SEC 8-K
- RESMED INCAppointed
Carol Burt lead director
Filed Aug 17, 2026Effective Nov 15, 2026SEC 8-K
- Rocket Companies, Inc.Appointed
Sarah Watterson Class III director
Filed Aug 17, 2026Effective Aug 17, 2026SEC 8-K
- SCANSOURCE, INC.Departed
Peter C. Browning Director
Filed Aug 17, 2026Effective Aug 12, 2026SEC 8-K